BIN3 inhibitors are a class of chemical compounds that specifically target the activity of Bridging Integrator 3 (BIN3), a protein involved in cellular processes such as membrane curvature and endocytosis. BIN3 is a member of the BAR (Bin/Amphiphysin/Rvs) domain-containing protein family, known for their ability to sense and induce membrane curvature. These proteins play a critical role in regulating various membrane dynamics, including vesicle formation, trafficking, and fusion. BIN3, in particular, is implicated in controlling the shape of membranes, and its inhibition alters the equilibrium of processes like vesicular transport, membrane scission, and cellular morphology. Inhibitors of BIN3 typically interact with its BAR domain, blocking its interaction with phospholipid membranes, which leads to alterations in the physical properties of cellular compartments. This inhibition can profoundly influence the intracellular trafficking of proteins and other molecules, highlighting BIN3's role in maintaining cellular architecture and transport fidelity.
On a molecular level, BIN3 inhibitors are often designed to engage with specific structural motifs within the protein to prevent its normal functioning. This can include blocking key amino acid residues that are essential for the BAR domain to bind to curved membrane surfaces or interacting with sites involved in the oligomerization of the protein. By perturbing these interactions, BIN3 inhibitors disrupt the formation of membrane tubules or vesicles, which can interfere with processes such as autophagy, endocytosis, and cytokinesis. These inhibitors provide valuable insight into the structural and mechanistic roles of BIN3, as well as the broader family of BAR domain proteins, in cellular homeostasis. This makes BIN3 inhibition a critical tool in studying cellular processes related to membrane dynamics, allowing researchers to explore its contributions to intracellular transport, membrane deformation, and cytoskeletal organization.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can alter chromatin structure and gene expression, potentially reducing BIN3 transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-Azacytidine may decrease methylation of the BIN3 gene promoter, leading to a downregulation of its expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects gene expression by activating retinoic acid receptors, which could suppress BIN3 expression through transcriptional regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, a pathway that can regulate protein synthesis and gene expression, potentially affecting BIN3 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may disrupt signaling pathways, potentially leading to decreased BIN3 expression through reduced transcriptional activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As an MEK inhibitor, PD98059 can alter MAPK pathway signaling, which might influence BIN3 expression by modulating transcription factor activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, potentially affecting transcription factors that regulate BIN3 gene expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can disrupt PI3K/Akt signaling, possibly leading to reduced transcription of the BIN3 gene. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor may change the expression of proteins, such as BIN3, by modulating the activity of transcription factors affected by this pathway. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, potentially reducing overall protein levels, including BIN3. | ||||||